Clinical & Non Clinical Applications
nGageIT Digital Medicine is working with health system providers and programs throughout the United States to improve levels of care for patients. This includes a number of significant clinical and commercial applications in which nGageIT can significantly help increase patient wellness and outcomes, improve treatment programs, reduce program and healthcare costs, and help bring key patient treatment issues to light.
The opioid crisis drastically affects areas of healthcare in the United States. For example, in 2015 alone, 52,000 people died of drug overdoses, with over 30,000 of those people dying from opioid drugs.
Hepatitis C / HCV
Approximately 3.5 million people in the United States are living with chronic HCV – it also affects over 180 million people worldwide and results in approximately 300,000 deaths annually due to cirrhosis.
In the US, Statin use among US adults 40 years of age and older in the general population increased 79.8% from 21.8 million individuals in 2002-2003 to 39.2 million individuals in 2012-2013.
25 to 30% of new oncology medications in development are oral agents. This is expected to rise as the industry experiences a paradigm shift in the process and outcomes in oncology care.
In the United States, more than 700,000 inmates leave prisons annually and more than two‐thirds have a drug problem. Less than one-quarter of them end up getting the treatment they need.
Nearly 17,000 people are waiting for a liver transplant in the United States. Once completed, several medications must be taken in order to prevent complications and rejection of the organ.
The global clinical trials market is said to be expected to reach USD 65.2 billion by 2025. The overall cost of failed clinical trails is estimated between $800 million and $1.4 billion USD.
Knowing when your body is performing optimally and when it is not is the critical factor that enables your understanding of if your program is working for you. Learn how we can help you.
Breathalyzer / Sobriety
Breathalyzers have long been used to test for alcohol consumption, but with new legalized drugs in market enhanced technology to support field sobriety tests is required.